207 related articles for article (PubMed ID: 12544726)
1. Görög Thrombosis Test: a global in-vitro test of platelet function and thrombolysis.
Yamamoto J; Yamashita T; Ikarugi H; Taka T; Hashimoto M; Ishii H; Watanabe S; Kovacs IB
Blood Coagul Fibrinolysis; 2003 Jan; 14(1):31-9. PubMed ID: 12544726
[TBL] [Abstract][Full Text] [Related]
2. Thrombolytic and antithrombotic efficacy of the platelet GPIIb-IIIa antagonist DMP728.
Mousa SA; Forsythe MS; Diemer M; Bozarth JM; Reilly TM
Coron Artery Dis; 1994 Nov; 5(11):919-27. PubMed ID: 7719524
[TBL] [Abstract][Full Text] [Related]
3. Clot lysis time in platelet-rich plasma: method assessment, comparison with assays in platelet-free and platelet-poor plasmas, and response to tranexamic acid.
Panes O; Padilla O; Matus V; Sáez CG; Berkovits A; Pereira J; Mezzano D
Platelets; 2012; 23(1):36-44. PubMed ID: 21787173
[TBL] [Abstract][Full Text] [Related]
4. Gorog Thrombosis Test: analysis of factors influencing occlusive thrombus formation.
Nishida H; Murata M; Miyaki K; Omae K; Watanabe K; Ikeda Y
Blood Coagul Fibrinolysis; 2006 Apr; 17(3):203-7. PubMed ID: 16575258
[TBL] [Abstract][Full Text] [Related]
5. Thrombotic status analyser. Measurement of platelet-rich thrombus formation and lysis in native blood.
Gorog DA; Kovacs IB
Thromb Haemost; 1995 Mar; 73(3):514-20. PubMed ID: 7667836
[TBL] [Abstract][Full Text] [Related]
6. Animal models for arterial thrombolysis and prevention of reocclusion. Erythrocyte-rich versus platelet-rich thrombus.
Gold HK; Yasuda T; Jang IK; Guerrero JL; Fallon JT; Leinbach RC; Collen D
Circulation; 1991 Jun; 83(6 Suppl):IV26-40. PubMed ID: 2040069
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of tissue-type plasminogen activator-induced thrombolysis and prevention of reocclusion by combination with a humanized anti-glycoprotein IIb/IIIa monoclonal antibody, YM337, in a rhesus monkey model of coronary thrombosis.
Kawasaki T; Sato K; Suzuki K; Sakai Y; Taniuchi Y; Kaku S; Yano S; Inagaki O; Tomioka K; Masuho Y; Yanagisawa I; Takenaka T
Thromb Haemost; 1998 Mar; 79(3):663-7. PubMed ID: 9531059
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of c7E3 Fab on thrombus formation and rt-PA-Mediated thrombolysis under flow conditions.
Huang TC; Jordan RE; Hantgan RR; Alevriadou BR
Thromb Res; 2001 Jun; 102(5):411-25. PubMed ID: 11395127
[TBL] [Abstract][Full Text] [Related]
9. A global platelet test of thrombosis and thrombolysis detects a prothrombotic state in some patients with non-insulin dependent diabetes and in some patients with stroke.
Nakajima S; Noguchi T; Taka T; Ueda T; Kaizu K; Fukamizu M; Fujita S; Tabuchi M; Yamamoto J
Platelets; 2000 Dec; 11(8):459-66. PubMed ID: 11177445
[TBL] [Abstract][Full Text] [Related]
10. Shear-induced global thrombosis test of native blood: pivotal role of ADP allows monitoring of P2Y12 antagonist therapy.
Saraf S; Wellsted D; Sharma S; Gorog DA
Thromb Res; 2009 Sep; 124(4):447-51. PubMed ID: 19476973
[TBL] [Abstract][Full Text] [Related]
11. FK419, a nonpeptide platelet glycoprotein IIb/IIIa antagonist, ameliorates brain infarction associated with thrombotic focal cerebral ischemia in monkeys: comparison with tissue plasminogen activator.
Maeda M; Moriguchi A; Mihara K; Aoki T; Takamatsu H; Matsuoka N; Mutoh S; Goto T
J Cereb Blood Flow Metab; 2005 Jan; 25(1):108-18. PubMed ID: 15678117
[TBL] [Abstract][Full Text] [Related]
12. Restoration of middle cerebral artery thrombosis by novel glycoprotein IIb/IIIa antagonist FK419 in guinea pig.
Moriguchi A; Mihara K; Aoki T; Maeda M; Tojo N; Matsuoka N; Mutoh S
Eur J Pharmacol; 2004 Sep; 498(1-3):179-88. PubMed ID: 15363993
[TBL] [Abstract][Full Text] [Related]
13. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W
Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of fibrinolysis by gel-filtered platelets and its quenching by cytochalasin B and GPIIb/IIIa antagonists.
Hoki S; Suzuki Y; Umemura K; Urano T
Pharmacol Rep; 2009; 61(5):877-84. PubMed ID: 19904011
[TBL] [Abstract][Full Text] [Related]
15. The effect of long-term, low-dose tranexamic acid treatment on platelet dysfunction and haemoglobin levels in haemodialysis patients.
Sabovic M; Zupan IP; Salobir B; Zupan I; Cernelc P; Lavre J; Vujkovac B
Thromb Haemost; 2005 Dec; 94(6):1245-50. PubMed ID: 16411401
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of plasminogen activator inhibitor-1 accelerates thrombolysis of a platelet-rich thrombus in rat mesenteric arterioles.
Rupin A; Martin F; Vallez MO; Bonhomme E; Verbeuren TJ
Thromb Haemost; 2001 Dec; 86(6):1528-31. PubMed ID: 11776323
[TBL] [Abstract][Full Text] [Related]
17. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.
Guimarães AH; Rijken DC
Thromb Haemost; 2004 Mar; 91(3):473-9. PubMed ID: 14983222
[TBL] [Abstract][Full Text] [Related]
18. A study of the use of the thromboxane A2 antagonist, sulotroban, in combination with streptokinase for local thrombolysis in patients with recent peripheral arterial occlusions: clinical effects, platelet function and fibrinolytic parameters.
Lonsdale RJ; Heptinstall S; Westby JC; Berridge DC; Wenham PW; Hopkinson BR; Makin GS
Thromb Haemost; 1993 Feb; 69(2):103-11, 123. PubMed ID: 8456421
[TBL] [Abstract][Full Text] [Related]
19. Reocclusion after thrombolytic therapy: strategies for inhibiting thrombin-induced platelet aggregation.
Puri RN; Colman RW
Blood Coagul Fibrinolysis; 1993 Jun; 4(3):465-78. PubMed ID: 8329574
[TBL] [Abstract][Full Text] [Related]
20. Activation of porcine endothelium in response to xenogeneic serum causes thrombosis independently of platelet activation.
Galbusera M; Buelli S; Gastoldi S; Macconi D; Angioletti S; Testa C; Remuzzi G; Morigi M
Xenotransplantation; 2005 Mar; 12(2):110-20. PubMed ID: 15693841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
